![Erica Whittaker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erica Whittaker
Director/Board Member at
Neurona Therapeutics, Inc.
Profile
Erica Whittaker is currently a Director at Neurona Therapeutics, Inc. and a Director at StrideBio, Inc. She is also a Director at SpliceBio SL, UCB Ventures (Private Equity), Rinri Therapeutics Ltd., and Exevir Bio BV.
Previously, she worked as a Research Analyst at Merrill Lynch, Pierce, Fenner & Smith Ltd.
Erica Whittaker active positions
| Companies | Position | Start |
|---|---|---|
Neurona Therapeutics, Inc.
 Neurona Therapeutics, Inc. BiotechnologyHealth Technology Operate as a pre-clinical stage biotechnology company | Director/Board Member | 2021-06-21 |
UCB Ventures London
 UCB Ventures London Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 2017-09-30 |
Exevir Bio BV
 Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Director/Board Member | - |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Director/Board Member | 2018-06-13 |
Rinri Therapeutics Ltd.
 Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops regenerative stem cell-based therapies for treatment of hearing loss | Director/Board Member | 2021-01-31 |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Director/Board Member | - |
UCB Ventures (Private Equity)
 UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures invests in healthcare venture capital funds located in the US and Europe. The operating division targets companies operating in the fields of health technology. It provides financing for early stage capital requirements. | Director/Board Member | - |
Former positions of Erica Whittaker
| Companies | Position | End |
|---|---|---|
Merrill Lynch, Pierce, Fenner & Smith Ltd.
 Merrill Lynch, Pierce, Fenner & Smith Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2008-12-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Operate as a pre-clinical stage biotechnology company | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith Ltd.
Merrill Lynch, Pierce, Fenner & Smith Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
SpliceBio SL
SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
UCB Ventures (Private Equity)
UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures invests in healthcare venture capital funds located in the US and Europe. The operating division targets companies operating in the fields of health technology. It provides financing for early stage capital requirements. | Finance |
UCB Ventures London
UCB Ventures London Investment ManagersFinance Acts as an alternative investment manager | Finance |
Rinri Therapeutics Ltd.
Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops regenerative stem cell-based therapies for treatment of hearing loss | Commercial Services |
Exevir Bio BV
Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Health Technology |
- Stock Market
- Insiders
- Erica Whittaker
